â– LECTURE OVERVIEW: Kawasaki Disease is an acute, self-limiting medium-vessel necrotizing vasculitis that primarily affects infants and toddlers.
â– SPECIFIC TOXIC CHANNELS:
1. Endothelial Inflammation: Characterized by segment-like inflammation of muscular medium arteries, particularly coronary arteries.
2. Clinical Diagnoses: Requires high fever lasting over 5 days, plus at least 4 of 5 CRASH symptoms:
- C - Conjunctivitis (bilateral, non-purulent, sparing the limbus).
- R - Rash (polymorphous, erythematous).
- A - Adenopathy (cervical, unilateral, node >1.5 cm).
- S - Strawberry tongue (erythematous, with cracked red lips).
- H - Hand/foot swelling initially, with desquamation of skin under nails in recovery.
â– PHYSIOLOGICAL METABOLIC RECOVERY LOOPS:
Intense pathologic strain initiates systemic arterial, neural, or renal neurohormonal feedback mechanisms to maintain oxygenation, cellular pH balance, and blood pressure in critical territories.
â– CLINICAL CASE SUMMARY:
A 45-year-old patient presented with acute clinical deterioration. Aggressive initial stabilization, molecular monitoring, and specialized pathology screening confirmed the classic disease hallmarks.
[HY-BOARD-1040]
🌟 Dynamic Clinical Key:
Carries a high risk of developing coronary artery aneurysms in up to 25% of untreated cases. Crucially, Kawasaki disease is the only clinical condition where Aspirin (which is otherwise contraindicated in children due to Reye's syndrome) is administered, alongside intravenous immunoglobulin (IVIG). Recognize that blocking some compensatory mechanisms (like reducing hyperventilation in respiratory compensation) can hasten acidotic collapse. Clinical vigilance during early presentation prevents progression along the severe outcome pathway.